05/24/2022 | Ken Lin | 2 min read
When I was asked about my favorite MIGS device, it was an easy question to answer: Trabectome!
05/05/2022 | Hannah C. Lamont
Disease research should embrace the biotechnology available to increase drug development success
04/14/2022 | Gerd Auffarth
Is there a more efficient approach to treat glaucoma patients who cannot maintain eye drop adherence?
04/07/2022 | Gregor Hawlina, Matej Beltram
An expert unpacking of the SLT ascension to first line treatment for glaucoma
03/24/2022 | Aleksandra Jones, Oscelle Boye
What have glaucoma researchers Ningli Wang – in China – and Ted Garway-Heath – in the UK – been busy with?
03/17/2022 | Ningli Wang
Despite pandemic-related challenges, my team have managed to make promising progress in glaucoma research, with a few major breakthroughs
03/15/2022 | Dan Lindfield
Two recent updates in the glaucoma field that are definitely worth shouting about
03/03/2022 | Hannah C. Lamont
Bringing the eye's "donut of drainage," aka trabecular meshwork and Schlemm’s canal models of glaucoma up to date with technology
02/10/2022 | Aleksandra Jones
How has glaucoma care and management changed since the start of 2020?
02/09/2022 | Sponsored by Glaukos
How can glaucoma be addressed during cataract surgery?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: